Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Thyroid carcinoma (TC) is a significant global health concern with incompletely understood carcinogenesis.
• MicroRNAs (miRNAs) are increasingly recognized for their role in cancer development, but their specific involvement in TC pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the role of miR-449b in thyroid carcinoma.
• To determine the relationship between miR-449b levels, patient survival, and cancer cell proliferation.
• To identify the molecular targets of miR-449b in thyroid carcinoma cells.

Main Methods:

• Analysis of miR-449b expression levels in TC tissues.
• In vitro manipulation of miR-449b levels using miRNA mimics and antisense inhibitors.
• Assessment of cell growth, proliferation, and apoptosis using CCK-8, MTT, and flow cytometry assays.
• Bioinformatic prediction and dual-luciferase reporter assays to identify and validate miR-449b targets.

Main Results:

• Significantly lower miR-449b levels were detected in TC tissues, correlating with poor patient survival.
• Overexpression of miR-449b inhibited TC cell growth, while its depletion enhanced growth, primarily by modulating cell proliferation.
• miR-449b directly targets the 3'-UTR of MET (hepatocyte growth factor receptor) mRNA, inhibiting its expression in TC cells.

Conclusions:

• Reduced miR-449b expression is a potential driver of thyroid carcinoma growth.
• The observed effects are mediated through the MET signaling pathway, highlighting miR-449b as a potential therapeutic target.